Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Alectinib in Crizotinib-Refractory <i>ALK-</i>Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study
PaperCitations, authors & open-access status
Alectinib in Crizotinib-Refractory <i>ALK-</i>Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 584 citations, 2015 year and closed oa status.
584
Citations
2015
Year
closed
OA Status